Physician profile
Cherilyn Kasperian
NPI 1841643905
$1,588.69
in general payments reported to CMS, 2019-2025
8 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.62 · 2020: $39.25 · 2021: $21.08 · 2022: $109 · 2023: $24.87 · 2024: $1,252 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $675 · Food and Beverage: $661 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $675.04 |
| Food and Beverage | $661.02 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,112.74 | 2022-2025 | |
| Henry Schein, INC. | $325.99 | 2019-2025 | Nuoss, Ace Surgical Supply, Allooss Allograft Putty |
| Orapharma, A Division of Bausch Health US, LLC | $60.04 | 2021-2023 | Arestin |
| Zimmer Biomet Holdings, INC. | $39.25 | 2020 | |
| Biohorizons Implant Systems INC. | $16.10 | 2024 | Mem-Lok Pliable, Mem-Lok |
| Dentsply Sirona INC | $14.98 | 2024 | Astra Tech Implant System |
| Philips North America LLC | $14.44 | 2022 | |
| Ace Surgical Supply Co., INC. | $5.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherilyn Kasperian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.